Alnylam Pharmaceuticals ALNY Balance Sheet Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $1.71B+3.2% | $1.66B+11.1% | $1.49B+33.8% | $1.12B+9.2% | $1.02B+5.5% | ||
| $1.3B+3.8% | $1.25B+1.4% | $1.23B-29.2% | $1.74B+8.6% | $1.61B-6.7% | ||
| $883.96M+13.7% | $777.57M-19.4% | $964.77M+70.1% | $567.11M+35.7% | $418.04M+3.1% | ||
| $84.03M+1.6% | $82.72M+9.7% | $75.38M+5.2% | $71.69M+9.3% | $65.58M-16.5% | ||
| $4.22B+4.2% | $4.05B+2.5% | $3.95B+8.5% | $3.64B+11.5% | $3.27B-0.8% | ||
| $518.26M+1.0% | $513.15M+2.3% | $501.75M+0.4% | $499.79M+0.2% | $498.68M-0.8% | ||
| $5.13B+3.3% | $4.97B+2.4% | $4.85B+6.3% | $4.57B+8.4% | $4.21B-0.6% | ||
| $3.21M-33.7% | $4.85M+90.7% | $2.54M-83.1% | $15.08M-46.4% | $28.16M-49.2% | ||
| $1.35B-8.0% | $1.47B-5.7% | $1.56B+19.6% | $1.3B+20.9% | $1.08B-9.3% | ||
| $4.05B-2.9% | $4.18B-9.5% | $4.62B+7.0% | $4.32B+5.3% | $4.1B-1.8% | ||
| 250M0.0% | 250M0.0% | 250M0.0% | 250M0.0% | 250M+19,235% | ||
| -$6.5B+3.1% | -$6.7B+6.4% | -$7.16B+3.4% | -$7.41B-0.9% | -$7.35B-0.8% | ||
| $1.08B+36.3% | $789.18M+237% | $233.89M-6.7% | $250.59M-41.2% | $426.14M+535% | ||
| $5.13B+3.3% | $4.97B+2.4% | $4.85B+6.3% | $4.57B+8.4% | $4.21B-0.6% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Alnylam Pharmaceuticals's total assets?
- Alnylam Pharmaceuticals (ALNY) holds $5.1B in total assets, up 21.7% year over year.
- How much debt does Alnylam Pharmaceuticals have?
- Alnylam Pharmaceuticals carries $263.7M in total debt against $1.1B of shareholders' equity, a debt-to-equity ratio of 0.25.
- How much cash does Alnylam Pharmaceuticals have?
- Alnylam Pharmaceuticals holds $1.7B in cash and equivalents.
- Can Alnylam Pharmaceuticals cover its short-term obligations?
- Its current ratio is 3.13 — current assets exceed current liabilities.
- Where does Alnylam Pharmaceuticals's balance sheet data come from?
- Every line is extracted from Alnylam Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
